The annual J.P. Morgan Healthcare Conference is “the largest and most informative healthcare investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.” (JPMorgan.com)
This year, we pulled the top headlines from Healthcare Marketing Daily (our complimentary newsletter for healthcare marketers!) to bring our readers up to speed on JPM 2024, which took place in San Francisco, California on January 8-11, 2024.
In case you missed it, check out the highlights below and sign up for Healthcare Marketing Daily to receive future industry insights directly to your inbox.
Conference Highlights
Clinical Research & Trials
Sanofi May Consider Potential of Next-Gen Weight Loss Drugs, Execs Say: Endpoints News
Novartis Has Been ‘Active’ In Neuroscience Business Development: FierceBiotech
Medical Devices
Hologic Has Become ‘Bigger, Faster, Stronger’ Through Strategic Acquisitions: FierceBiotech
Payers
Bluebird Bio CEO Defends Lyfgenia’s Pricing With Outcomes-Based Contracts: FiercePharma
Providers
Amazon, Omada Health Launches New Program Offering Virtual Benefits: Fierce Healthcare
Technology
Socially Determined, Uber Health To Collaborate On Health Analytics: Fierce Healthcare
Therapeutics
Pfizer Among Biopharma Companies Emphasizing Renewal: Medical Marketing & Media
BMS Expects To Add 16 New Products By 2030, CEO Says: Reuters
Sanofi CEO Open-Minded To M&A, Reiterates Ambitions For ‘New’ Company: Endpoints News
Novo Nordisk ‘Just Getting Going’ In Obesity Drug Field, CEO Says: FiercePharma
Johnson & Johnson To Acquire ADC Specialist Ambrx Biopharma For $2 Billion: CNBC
AbbVie Confident It Will Retain Strong Botox Market Share Amid Rivals: Reuters
Biogen CEO Talks Leqembi Launch Progress At JPM: BioPharma Dive
Don’t forget to sign up for Healthcare Marketing Daily, follow us on LinkedIn, and return to this space for more industry insights like this!
